Table 1 Characteristics of study population by facility
Variable | Total facility n (%) | NAUMC Awka n (%) | NAUTH Nnewi n (%) | Chi square difference | p-value |
|---|---|---|---|---|---|
Total number of outpatients visits | 7926 | 2674 | 5252 | - | - |
Proportion of malaria cases | 2171 (27) | 1261 (47) | 910 (17) | 729.8 | 0.0001*** |
Mode of diagnosis | |||||
Microscopy | 939 (43) | 650 (52) | 288 (32) | 9.95 | 0.0016** |
RDT | 128 (6) | - | 128 (14) | - | - |
Presumptive | 1105 (51) | 611 (48) | 494 (54) | 0.875 | 0.3497 |
Gender | |||||
Female | 1207 (56) | 635 (50.4) | 573 (63.0) | 42.09 | 0.0001*** |
Male | 942 (43) | 626 (49.6) | 316 (34.7) | - | - |
Unknown | 22 (1.0) | - | 21 (2.3) | - | - |
Age category (yrs) | 20.29 | 0.0001*** | |||
Under 5 | 214 (10) | 33 (2.6) | 181 (20) | - | - |
5 – 12 | 52 (2) | 22 (1.7) | 30 (3) | - | - |
13 – 18 | 104 (5) | 78 (6.2) | 36 (3) | - | - |
19 and above | 1354 (62) | 1026 (81.4) | 330 (36) | - | - |
Unknown | 447 (21) | 102 (8.0) | 343 (38) | - | - |
Median age of cohort (range) | 23 (0.1 – 98) | 23 (1 – 82) | 24 (0.1 – 98) | ||
Antimalarial drugs | |||||
ACT | 2027 (93) | 1198 (95) | 828 (91) | 13.02 | 0.0003*** |
Monotherapy | 144 (7) | 63 (5) | 81 (9) | - | - |